Pfizer Ramps Up Production Amid Pause On J&J Vax

MarketWatch reports:

Pfizer Inc. Chief Executive Albert Bourla tweeted late Tuesday that the pharma company has “ramped up” production of its COVID-19 vaccine, and will be able to deliver 10% more doses to the U.S. by the end of May than a previously agreed total of 220 million doses, as well as supply “the full (300 million doses) agreed on for the end of July two weeks early.”

Read the full article.

Pfizer ramps up COVID-19 vaccine production for the U.S., CEO says https://t.co/MwPFVtZnCx

— MarketWatch (@MarketWatch) April 13, 2021

.@Pfizer has ramped up production of our #COVID19 vaccine & can deliver 10% more doses to the US by the end of May than previously agreed (total of 220M) & supply the full 300M agreed on for the end of July two weeks early. In the fight against COVID-19, we’re in this together.

— AlbertBourla (@AlbertBourla) April 13, 2021